Delving into the Latest Updates on Aspen Pharmacare Australia Pty Ltd. with Synapse

Overview

Tags

Other Diseases

Infectious Diseases

Nervous System Diseases

Small molecule drug

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Infectious Diseases	10
Nervous System Diseases	9
Immune System Diseases	3
Endocrinology and Metabolic Disease	2
Hemic and Lymphatic Diseases	2
Neoplasms	1

Top 5 Drug Type	Count

Small molecule drug	20

Top 5 Target	Count

GABAA receptor(Gamma-aminobutyric acid A receptor)	3
PBPs(Bacterial penicillin-binding protein)	3
mAChRs(Muscarinic acetylcholine receptor)	2
SCNA x VDCCs	1
Electron transport complex III	1

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 31 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

20

Login to view more data

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Glycopyrrolate ( mAChRs )	Bradycardia More	Approved
Ranitidine Hydrochloride ( H2 receptor )	Duodenal Ulcer More	Approved
Amoxicillin/Clavulanate Potassium ( PBPs x β-lactamase )	Skin and skin structure infections More	Approved
Atropine Sulfate ( mAChRs )	Myopia More	Approved
Ondansetron Hydrochloride ( 5-HT3 receptor )	Postoperative Nausea and Vomiting More	Approved